United Therapeutics Corporation Other Noncash Income (Expense)
United Therapeutics Corporation (UTHR) reported Other Noncash Income (Expense) of -$56.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-05
- United Therapeutics Corporation other noncash income (expense) for the quarter ending 2026-06-30 was -$24.80M.
- United Therapeutics Corporation other noncash income (expense) for the quarter ending 2026-03-31 was -$32.00M.
- United Therapeutics Corporation other noncash income (expense) for the quarter ending 2025-12-31 was $33.60M, a 1192.31% increase year-over-year.
- United Therapeutics Corporation other noncash income (expense) for the quarter ending 2025-09-30 was -$9.20M, a 261.40% decline year-over-year.
- United Therapeutics Corporation other noncash income (expense) for fiscal 2025 was $19.70M, a 18.93% decline from fiscal 2024.
- United Therapeutics Corporation other noncash income (expense) for fiscal 2024 was $24.30M, a 395.92% increase from fiscal 2023.
- United Therapeutics Corporation other noncash income (expense) for fiscal 2023 was $4.90M.
- United Therapeutics Corporation other noncash income (expense) for fiscal 2022 was -$52.50M.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$24.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$56.80M 10-Q · filed 2026-08-05 | -$23.20M derived: sum of 3 quarters · filed 2026-08-05 | -$32.40M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$32.00M 10-Q · filed 2026-05-06 | $1.60M derived: sum of 2 quarters · filed 2026-05-06 | -$7.60M derived: sum of 3 quarters · filed 2026-05-06 | -$8.20M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $33.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $24.40M derived: sum of 2 quarters · filed 2026-02-25 | $23.80M derived: sum of 3 quarters · filed 2026-08-05 | $19.70M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | -$9.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$9.80M derived: sum of 2 quarters · filed 2026-08-05 | -$13.90M 10-Q · filed 2025-10-29 | -$11.30M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | -$600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$4.70M 10-Q · filed 2026-08-05 | -$14.00M 10-Q · filed 2025-07-30 | -$2.10M derived: sum of 3 quarters · filed 2026-08-05 | $3.60M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | -$4.10M 10-Q · filed 2026-05-06 | -$9.40M 10-Q · filed 2025-04-30 | -$1.50M derived: sum of 2 quarters · filed 2026-05-06 | $4.20M derived: sum of 3 quarters · filed 2026-05-06 | $9.70M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $8.30M derived: sum of 2 quarters · filed 2026-02-25 | $13.80M derived: sum of 3 quarters · filed 2026-02-25 | $24.30M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $5.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $11.20M derived: sum of 2 quarters · filed 2025-10-29 | $21.70M 10-Q · filed 2025-10-29 | $26.70M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $5.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $16.00M 10-Q · filed 2025-07-30 | $21.00M derived: sum of 3 quarters · filed 2026-02-25 | $22.80M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $10.50M 10-Q · filed 2025-04-30 | $15.50M derived: sum of 2 quarters · filed 2026-02-25 | $17.30M derived: sum of 3 quarters · filed 2026-02-25 | $21.20M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $6.80M derived: sum of 2 quarters · filed 2026-02-25 | $10.70M derived: sum of 3 quarters · filed 2026-02-25 | $4.90M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $5.70M derived: sum of 2 quarters · filed 2024-10-30 | -$100.00K 10-Q · filed 2024-10-30 | -$8.00M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | $3.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$1.90M 10-Q · filed 2024-07-31 | -$9.80M derived: sum of 3 quarters · filed 2025-02-26 | -$19.80M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | -$5.80M 10-Q · filed 2024-05-01 | -$13.70M derived: sum of 2 quarters · filed 2025-02-26 | -$23.70M derived: sum of 3 quarters · filed 2025-02-26 | -$70.50M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | -$7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$17.90M derived: sum of 2 quarters · filed 2025-02-26 | -$64.70M derived: sum of 3 quarters · filed 2025-02-26 | -$52.50M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | -$10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$56.80M derived: sum of 2 quarters · filed 2023-11-01 | -$44.60M 10-Q · filed 2023-11-01 | -$82.50M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-06-30 | -$46.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$34.60M 10-Q · filed 2023-08-02 | -$72.50M derived: sum of 3 quarters · filed 2024-02-21 | -$103.50M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-03-31 | $12.20M 10-Q · filed 2023-05-03 | -$25.70M derived: sum of 2 quarters · filed 2024-02-21 | -$56.70M derived: sum of 3 quarters · filed 2024-02-21 | -$62.20M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | -$37.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$68.90M derived: sum of 2 quarters · filed 2024-02-21 | -$74.40M derived: sum of 3 quarters · filed 2024-02-21 | -$65.90M 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | -$31.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$36.50M derived: sum of 2 quarters · filed 2022-11-02 | -$28.00M 10-Q · filed 2022-11-02 | $12.10M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | -$5.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $3.00M 10-Q · filed 2022-08-03 | $43.10M derived: sum of 3 quarters · filed 2023-02-22 | $37.20M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $8.50M 10-Q · filed 2022-05-04 | $48.60M derived: sum of 2 quarters · filed 2023-02-22 | $42.70M derived: sum of 3 quarters · filed 2023-02-22 | $32.70M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $40.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $34.20M derived: sum of 2 quarters · filed 2023-02-22 | $24.20M derived: sum of 3 quarters · filed 2023-02-22 | $47.00M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | -$5.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$15.90M derived: sum of 2 quarters · filed 2021-11-03 | $6.90M 10-Q · filed 2021-11-03 | $6.80M 10-Q · filed 2020-10-28 | $8.70M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | -$10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $12.80M 10-Q · filed 2021-08-04 | $13.90M 10-Q · filed 2020-07-29 | $14.60M derived: sum of 3 quarters · filed 2022-02-24 | $5.50M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-03-31 | $22.80M 10-Q · filed 2021-05-05 | $24.60M derived: sum of 2 quarters · filed 2022-02-24 | $15.50M derived: sum of 3 quarters · filed 2022-02-24 | $59.20M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$7.30M derived: sum of 2 quarters · filed 2022-02-24 | $36.40M derived: sum of 3 quarters · filed 2022-02-24 | $29.70M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | -$9.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $34.60M derived: sum of 2 quarters · filed 2020-10-28 | $27.90M 10-Q · filed 2020-10-28 | $30.50M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | $43.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $37.00M 10-Q · filed 2020-07-29 | $39.60M derived: sum of 3 quarters · filed 2021-02-24 | $33.10M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | -$6.70M 10-Q · filed 2020-04-29 | -$4.10M derived: sum of 2 quarters · filed 2021-02-24 | -$10.60M derived: sum of 3 quarters · filed 2021-02-24 | -$8.60M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$3.90M derived: sum of 2 quarters · filed 2021-02-24 | -$1.90M derived: sum of 3 quarters · filed 2021-02-24 | -$1.80M 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | -$6.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$4.50M derived: sum of 2 quarters · filed 2019-10-30 | -$4.40M 10-Q · filed 2019-10-30 | $5.80M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $2.10M 10-Q · filed 2019-07-31 | $12.30M derived: sum of 3 quarters · filed 2020-02-26 | $11.60M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | $100.00K 10-Q · filed 2019-05-01 | $10.30M derived: sum of 2 quarters · filed 2020-02-26 | $9.60M derived: sum of 3 quarters · filed 2020-02-26 | $11.00M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2017-12-31 | $10.20M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $9.50M derived: sum of 2 quarters · filed 2020-02-26 | $10.90M derived: sum of 3 quarters · filed 2020-02-26 | $19.40M 10-K · filed 2020-02-26 | ||||
| 2017-09-30 | -$700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $700.00K derived: sum of 2 quarters · filed 2018-10-31 | $9.20M 10-Q · filed 2018-10-31 | $2.20M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $9.90M 10-Q · filed 2018-08-01 | $2.90M derived: sum of 3 quarters · filed 2019-02-27 | $1.90M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $8.50M 10-Q · filed 2018-05-02 | $1.50M derived: sum of 2 quarters · filed 2019-02-27 | $500.00K derived: sum of 3 quarters · filed 2019-02-27 | -$2.10M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | -$7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$8.00M derived: sum of 2 quarters · filed 2019-02-27 | -$10.60M derived: sum of 3 quarters · filed 2019-02-27 | -$9.50M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-25 | -$3.60M derived: sum of 2 quarters · filed 2017-10-25 | -$2.50M 10-Q · filed 2017-10-25 | -$4.10M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-06-30 | -$2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | -$1.50M 10-Q · filed 2017-07-27 | -$1.10M 10-Q · filed 2016-07-28 | -$3.10M derived: sum of 3 quarters · filed 2018-02-21 | -$13.50M derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2016-03-31 | $1.10M 10-Q · filed 2017-04-26 | $1.40M 10-Q · filed 2016-04-28 | -$500.00K derived: sum of 2 quarters · filed 2018-02-21 | -$10.90M derived: sum of 3 quarters · filed 2018-02-21 | -$8.20M derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2015-12-31 | -$1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | -$12.00M derived: sum of 2 quarters · filed 2018-02-21 | -$9.30M derived: sum of 3 quarters · filed 2018-02-21 | -$7.50M 10-K · filed 2018-02-21 | $515.00K 10-K · filed 2016-02-25 | |||
| 2015-09-30 | -$10.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | -$7.70M derived: sum of 2 quarters · filed 2016-10-27 | -$5.90M 10-Q · filed 2016-10-27 | $1.53M 10-Q · filed 2015-10-27 | -$28.62M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2015-06-30 | $2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $4.50M 10-Q · filed 2016-07-28 | $4.50M 10-Q · filed 2015-07-28 | -$18.22M derived: sum of 3 quarters · filed 2017-02-22 | -$18.66M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2015-03-31 | $1.80M 10-Q · filed 2016-04-28 | $1.84M 10-Q · filed 2015-04-28 | -$20.92M derived: sum of 2 quarters · filed 2017-02-22 | -$21.36M derived: sum of 3 quarters · filed 2017-02-22 | -$21.74M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2014-12-31 | -$22.72M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | -$23.16M derived: sum of 2 quarters · filed 2017-02-22 | -$23.54M derived: sum of 3 quarters · filed 2017-02-22 | -$24.20M 10-K · filed 2017-02-22 | -$6.49M 10-K · filed 2015-02-24 | |||
| 2014-09-30 | -$439.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | -$820.00K derived: sum of 2 quarters · filed 2015-10-27 | -$1.48M 10-Q · filed 2015-10-27 | -$3.55M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-06-30 | -$381.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-28 | -$1.04M 10-Q · filed 2015-07-28 | $414.00K 10-Q · filed 2014-07-29 | -$3.11M derived: sum of 3 quarters · filed 2016-02-25 | -$2.91M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2014-03-31 | -$658.00K 10-Q · filed 2015-04-28 | -$199.00K 10-Q · filed 2014-04-29 | -$2.73M derived: sum of 2 quarters · filed 2016-02-25 | -$2.53M derived: sum of 3 quarters · filed 2016-02-25 | -$3.53M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2013-12-31 | -$2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | -$1.87M derived: sum of 2 quarters · filed 2016-02-25 | -$2.87M derived: sum of 3 quarters · filed 2016-02-25 | -$3.18M 10-K · filed 2016-02-25 | -$592.00K 10-K · filed 2014-02-25 | |||
| 2013-09-30 | $205.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | -$797.00K derived: sum of 2 quarters · filed 2014-10-28 | -$1.11M 10-Q · filed 2014-10-28 | -$1.18M 10-Q · filed 2013-10-29 | -$6.76M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-06-30 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-29 | -$1.31M 10-Q · filed 2014-07-29 | -$6.96M derived: sum of 3 quarters · filed 2015-02-24 | -$7.57M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | -$311.00K 10-Q · filed 2014-04-29 | -$5.96M derived: sum of 2 quarters · filed 2015-02-24 | -$6.57M derived: sum of 3 quarters · filed 2015-02-24 | -$14.76M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | -$5.65M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$6.26M derived: sum of 2 quarters · filed 2015-02-24 | -$14.45M derived: sum of 3 quarters · filed 2015-02-24 | -$14.47M 10-K · filed 2015-02-24 | -$1.43M 10-K · filed 2013-02-26 | |||
| 2012-09-30 | -$610.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | -$8.80M derived: sum of 2 quarters · filed 2013-10-29 | -$8.82M 10-Q · filed 2013-10-29 | -$8.18M 10-Q · filed 2012-11-01 | -$9.32M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-06-30 | -$8.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | -$8.21M 10-Q · filed 2013-07-25 | -$8.71M derived: sum of 3 quarters · filed 2014-02-25 | -$2.88M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | -$26.00K 10-Q · filed 2013-04-25 | -$526.00K derived: sum of 2 quarters · filed 2014-02-25 | $5.30M derived: sum of 3 quarters · filed 2014-02-25 | $4.13M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | -$500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $5.33M derived: sum of 2 quarters · filed 2014-02-25 | $4.15M derived: sum of 3 quarters · filed 2014-02-25 | -$2.61M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $5.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $4.65M derived: sum of 2 quarters · filed 2012-11-01 | -$2.11M 10-Q · filed 2012-11-01 | |||||
| 2011-06-30 | -$1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | -$7.94M 10-Q · filed 2012-07-26 | ||||||
| 2011-03-31 | -$6.77M 10-Q · filed 2012-04-26 | |||||||
| 2010-12-31 | -$967.00K 10-K · filed 2013-02-26 | |||||||
| 2009-12-31 | $1.85M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |